2. News
  3. QIAGEN
     Page  1 2 3  ... Next 
QIAGEN launches CE-marked version of QuantiFERON® SARS-CoV-2 to assess T-cell response to COVID-1922 Dec 2021
QIAGEN reaffirms effectiveness of its SARS-CoV-2 PCR tests in light of the new coronavirus variant B.1.1.52926 Nov 2021
QIAGEN announces the commercialization of the PreAnalytiX PAXgene Saliva Collector2 Sep 2021
QIAGEN receives FDA authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen20 Aug 2021
QIAGEN and GT Molecular collaborate to offer a complete SARS-CoV-2 wastewater detection solution19 Aug 2021
QIAGEN’s NeuMoDx HAdV Quant Assay secures CE-IVD certification for automated testing to detect human adenovirus infections13 Jul 2021
QIAGEN launches dedicated CRISPR products for rapid and simplified analysis of gene-editing experiments22 Jun 2021
QIAGEN launches first FDA-approved tissue companion diagnostic to identify the KRAS G12C mutation in NSCLC tumours and expand precision medicine options in lung cancer3 Jun 2021
QIAGEN partners with Mirati Therapeutics to develop KRAS-G12C companion diagnostic for non-small-cell lung cancer27 May 2021
QIAGEN receives U.S. FDA Emergency Use Authorization for fast and easy-to-use digital test to detect SARS-CoV-2 coronavirus antibodies21 May 2021